Azenta, Inc. (AZTA)
USD 49.65
(7.21%)
USD 49.65
(7.21%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -618.47 Million USD | -1.55% |
| 2022 | -609.04 Million USD | -359.1% |
| 2021 | -132.66 Million USD | 37.83% |
| 2020 | -213.37 Million USD | 14.82% |
| 2019 | -250.49 Million USD | -15202.26% |
| 2018 | -1.63 Million USD | 98.39% |
| 2017 | -101.62 Million USD | -19.43% |
| 2016 | -85.08 Million USD | -5.41% |
| 2015 | -80.72 Million USD | 5.94% |
| 2014 | -85.81 Million USD | -3.43% |
| 2013 | -82.97 Million USD | -51.85% |
| 2012 | -54.63 Million USD | 7.13% |
| 2011 | -58.83 Million USD | 1.65% |
| 2010 | -59.82 Million USD | -21.52% |
| 2009 | -49.23 Million USD | 55.35% |
| 2008 | -110.26 Million USD | 34.45% |
| 2007 | -168.23 Million USD | -45.33% |
| 2006 | -115.76 Million USD | -321.74% |
| 2005 | -27.44 Million USD | -50.35% |
| 2004 | -18.25 Million USD | -136.42% |
| 2003 | 50.12 Million USD | 0.47% |
| 2002 | 49.88 Million USD | 54.42% |
| 2001 | 32.3 Million USD | 128.24% |
| 2000 | -114.4 Million USD | -75.73% |
| 1999 | -65.1 Million USD | 4.12% |
| 1998 | -67.9 Million USD | 4.63% |
| 1997 | -71.2 Million USD | -71100.0% |
| 1996 | -100 Thousand USD | 99.29% |
| 1995 | -14 Million USD | -551.61% |
| 1994 | 3.1 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -265.15 Million USD | 6.11% |
| 2024 Q2 | -282.4 Million USD | 55.63% |
| 2024 Q1 | -636.44 Million USD | -2.91% |
| 2023 Q1 | -555.81 Million USD | 8.74% |
| 2023 Q4 | -618.47 Million USD | 7.91% |
| 2023 Q2 | -610.22 Million USD | -9.79% |
| 2023 Q3 | -671.57 Million USD | -10.05% |
| 2023 FY | -618.47 Million USD | -1.55% |
| 2022 Q4 | -609.04 Million USD | 57.33% |
| 2022 FY | -609.04 Million USD | -359.1% |
| 2022 Q1 | -121.66 Million USD | 8.29% |
| 2022 Q2 | -1.88 Billion USD | -1451.48% |
| 2022 Q3 | -1.42 Billion USD | 24.38% |
| 2021 Q4 | -132.66 Million USD | 24.27% |
| 2021 Q1 | -224.3 Million USD | -5.12% |
| 2021 FY | -132.66 Million USD | 37.83% |
| 2021 Q2 | -237.28 Million USD | -5.79% |
| 2021 Q3 | -175.17 Million USD | 26.18% |
| 2020 Q1 | -264.04 Million USD | -5.41% |
| 2020 Q2 | -164.26 Million USD | 37.79% |
| 2020 Q3 | -176.96 Million USD | -7.73% |
| 2020 Q4 | -213.37 Million USD | -20.58% |
| 2020 FY | -213.37 Million USD | 14.82% |
| 2019 Q1 | 405.01 Million USD | 24841.48% |
| 2019 Q4 | -250.49 Million USD | -165.2% |
| 2019 FY | -250.49 Million USD | -15202.26% |
| 2019 Q3 | 384.22 Million USD | -5.43% |
| 2019 Q2 | 406.28 Million USD | 0.31% |
| 2018 Q1 | -5.07 Million USD | 95.01% |
| 2018 FY | -1.63 Million USD | 98.39% |
| 2018 Q4 | -1.63 Million USD | -109.58% |
| 2018 Q3 | 17.09 Million USD | 498.95% |
| 2018 Q2 | 2.85 Million USD | 156.29% |
| 2017 Q4 | -101.62 Million USD | 13.2% |
| 2017 FY | -101.62 Million USD | -19.43% |
| 2017 Q1 | -82.94 Million USD | 2.52% |
| 2017 Q2 | -103.93 Million USD | -25.31% |
| 2017 Q3 | -117.08 Million USD | -12.64% |
| 2016 Q2 | -62.16 Million USD | -11.86% |
| 2016 Q4 | -85.08 Million USD | -28.69% |
| 2016 FY | -85.08 Million USD | -5.41% |
| 2016 Q1 | -55.57 Million USD | 31.16% |
| 2016 Q3 | -66.11 Million USD | -6.36% |
| 2015 Q1 | -69.58 Million USD | 18.92% |
| 2015 Q2 | -65.12 Million USD | 6.41% |
| 2015 Q3 | -71.74 Million USD | -10.16% |
| 2015 Q4 | -80.72 Million USD | -12.52% |
| 2015 FY | -80.72 Million USD | 5.94% |
| 2014 FY | -85.81 Million USD | -3.43% |
| 2014 Q4 | -85.81 Million USD | 19.89% |
| 2014 Q1 | -78.01 Million USD | 5.97% |
| 2014 Q2 | -76.74 Million USD | 1.63% |
| 2014 Q3 | -107.12 Million USD | -39.59% |
| 2013 Q3 | -61.88 Million USD | -2.94% |
| 2013 Q2 | -60.12 Million USD | -9.46% |
| 2013 Q1 | -54.92 Million USD | -0.52% |
| 2013 FY | -82.97 Million USD | -51.85% |
| 2013 Q4 | -82.97 Million USD | -34.07% |
| 2012 Q1 | -49.21 Million USD | 16.35% |
| 2012 Q2 | -81.15 Million USD | -64.91% |
| 2012 Q3 | -61.56 Million USD | 24.14% |
| 2012 Q4 | -54.63 Million USD | 11.25% |
| 2012 FY | -54.63 Million USD | 7.13% |
| 2011 Q1 | -62.31 Million USD | -4.16% |
| 2011 FY | -58.83 Million USD | 1.65% |
| 2011 Q3 | -133.11 Million USD | -124.37% |
| 2011 Q2 | -59.32 Million USD | 4.79% |
| 2011 Q4 | -58.83 Million USD | 55.8% |
| 2010 Q1 | -47.16 Million USD | 4.2% |
| 2010 FY | -59.82 Million USD | -21.52% |
| 2010 Q4 | -59.82 Million USD | -8.79% |
| 2010 Q3 | -54.98 Million USD | -46.54% |
| 2010 Q2 | -37.52 Million USD | 20.44% |
| 2009 FY | -49.23 Million USD | 55.35% |
| 2009 Q1 | -78.1 Million USD | 29.17% |
| 2009 Q2 | -49.15 Million USD | 37.06% |
| 2009 Q3 | -52.93 Million USD | -7.69% |
| 2009 Q4 | -49.23 Million USD | 7.0% |
| 2008 Q1 | -144.55 Million USD | 14.07% |
| 2008 Q2 | -113.26 Million USD | 21.65% |
| 2008 Q3 | -109.96 Million USD | 2.92% |
| 2008 Q4 | -110.26 Million USD | -0.28% |
| 2008 FY | -110.26 Million USD | 34.45% |
| 2007 Q2 | -252.67 Million USD | -88.42% |
| 2007 Q1 | -134.1 Million USD | -15.84% |
| 2007 FY | -168.23 Million USD | -45.33% |
| 2007 Q4 | -168.23 Million USD | 44.48% |
| 2007 Q3 | -302.99 Million USD | -19.91% |
| 2006 Q4 | -115.76 Million USD | -302.42% |
| 2006 Q2 | -5.53 Million USD | 70.45% |
| 2006 Q1 | -18.72 Million USD | 31.79% |
| 2006 FY | -115.76 Million USD | -321.74% |
| 2006 Q3 | 57.18 Million USD | 1133.75% |
| 2005 Q1 | 23.37 Million USD | 228.02% |
| 2005 Q2 | -21.39 Million USD | -191.55% |
| 2005 Q3 | 12.22 Million USD | 157.12% |
| 2005 FY | -27.44 Million USD | -50.35% |
| 2005 Q4 | -27.44 Million USD | -324.6% |
| 2004 Q2 | 6.48 Million USD | 117.44% |
| 2004 Q4 | -18.25 Million USD | 6.85% |
| 2004 Q3 | -19.59 Million USD | -402.21% |
| 2004 FY | -18.25 Million USD | -136.42% |
| 2004 Q1 | -37.17 Million USD | -174.17% |
| 2003 Q3 | 37.44 Million USD | -15.69% |
| 2003 FY | 50.12 Million USD | 0.47% |
| 2003 Q4 | 50.12 Million USD | 33.85% |
| 2003 Q2 | 44.41 Million USD | -32.07% |
| 2003 Q1 | 65.39 Million USD | 31.07% |
| 2002 Q2 | 91.18 Million USD | 40.85% |
| 2002 Q1 | 64.74 Million USD | 100.4% |
| 2002 Q3 | 53.98 Million USD | -40.8% |
| 2002 Q4 | 49.88 Million USD | -7.58% |
| 2002 FY | 49.88 Million USD | 54.42% |
| 2001 Q3 | -2.41 Million USD | 96.55% |
| 2001 Q4 | 32.3 Million USD | 1438.28% |
| 2001 Q2 | -70.06 Million USD | -5.65% |
| 2001 Q1 | -66.31 Million USD | 42.03% |
| 2001 FY | 32.3 Million USD | 128.24% |
| 2000 Q2 | -239.71 Million USD | -300.19% |
| 2000 FY | -114.4 Million USD | -75.73% |
| 2000 Q1 | -59.9 Million USD | 7.99% |
| 2000 Q4 | -114.4 Million USD | 47.06% |
| 2000 Q3 | -216.08 Million USD | 9.86% |
| 1999 Q2 | -69.3 Million USD | 1.56% |
| 1999 Q1 | -70.4 Million USD | -3.68% |
| 1999 FY | -65.1 Million USD | 4.12% |
| 1999 Q4 | -65.1 Million USD | 4.41% |
| 1999 Q3 | -68.1 Million USD | 1.73% |
| 1998 Q4 | -67.9 Million USD | -4.3% |
| 1998 Q1 | -68.8 Million USD | 3.37% |
| 1998 FY | -67.9 Million USD | 4.63% |
| 1998 Q2 | -65.2 Million USD | 5.23% |
| 1998 Q3 | -65.1 Million USD | 0.15% |
| 1997 Q3 | 10.4 Million USD | 67.74% |
| 1997 Q2 | 6.2 Million USD | 129.63% |
| 1997 FY | -71.2 Million USD | -71100.0% |
| 1997 Q1 | 2.7 Million USD | 2800.0% |
| 1997 Q4 | -71.2 Million USD | -784.62% |
| 1996 FY | -100 Thousand USD | 99.29% |
| 1996 Q2 | -1.2 Million USD | 0.0% |
| 1996 Q4 | -100 Thousand USD | 96.15% |
| 1996 Q3 | -2.6 Million USD | -116.67% |
| 1995 Q4 | -14 Million USD | 0.0% |
| 1995 FY | -14 Million USD | -551.61% |
| 1994 FY | 3.1 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 2.58 Million USD | 24062.573% |
| AngioDynamics, Inc. | -70.14 Million USD | -781.746% |
| AtriCure, Inc. | -9.81 Million USD | -6200.672% |
| Avinger, Inc. | 10.12 Million USD | 6211.403% |
| BioLife Solutions, Inc. | 7.25 Million USD | 8627.147% |
| The Cooper Companies, Inc. | 2.44 Billion USD | 125.26% |
| Daxor Corporation | 755.65 Thousand USD | 81945.647% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | -41973.061% |
| Femasys Inc. | -15.01 Million USD | -4018.987% |
| GlucoTrack, Inc. | -4.29 Million USD | -14296.508% |
| Harvard Bioscience, Inc. | 38.49 Million USD | 1706.843% |
| Hologic, Inc. | 374.4 Million USD | 265.191% |
| ICU Medical, Inc. | 1.45 Billion USD | 142.639% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 76.752% |
| KORU Medical Systems, Inc. | -7.03 Million USD | -8688.737% |
| LeMaitre Vascular, Inc. | -5.17 Million USD | -11853.498% |
| Innovative Eyewear, Inc. | -4.28 Million USD | -14325.228% |
| Innovative Eyewear, Inc. | -4.28 Million USD | -14325.228% |
| Masimo Corporation | 804 Million USD | 176.925% |
| Microbot Medical Inc. | -2.28 Million USD | -26954.856% |
| Meihua International Medical Technologies Co., Ltd. | -9.59 Million USD | -6345.295% |
| Merit Medical Systems, Inc. | 302.22 Million USD | 304.642% |
| Nephros, Inc. | -2.47 Million USD | -24929.3% |
| NovoCure Limited | 355.42 Million USD | 274.012% |
| NEXGEL, Inc. | 98 Thousand USD | 631195.918% |
| NEXGEL, Inc. | 98 Thousand USD | 631195.918% |
| Singular Genomics Systems, Inc. | 59.05 Million USD | 1147.285% |
| OraSure Technologies, Inc. | -276.9 Million USD | -123.354% |
| Pro-Dex, Inc. | 10.91 Million USD | 5765.757% |
| Pulse Biosciences, Inc. | -35.22 Million USD | -1655.981% |
| Predictive Oncology Inc. | -5.87 Million USD | -10432.872% |
| Precision Optics Corporation, Inc. | 3.02 Million USD | 20517.188% |
| QuidelOrtho Corporation | 2.49 Billion USD | 124.787% |
| Repligen Corporation | -39.51 Million USD | -1465.004% |
| Sanara MedTech Inc. | 6.64 Million USD | 9407.507% |
| STAAR Surgical Company | -147.2 Million USD | -320.148% |
| Sharps Technology, Inc. | -3.01 Million USD | -20427.477% |
| Utah Medical Products, Inc. | -92.52 Million USD | -568.433% |
| DENTSPLY SIRONA Inc. | 1.96 Billion USD | 131.475% |
| Jin Medical International Ltd. | -2.81 Million USD | -21858.894% |